Developed by Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed : October 2009 Most recently updated: September 2011

Similar documents
AMI Talking Points. Provide appropriate treatment to Acute MI patients with these core measures:

IMPORTANT INFORMATION REGARDING YOUR NUCLEAR STRESS TEST

ALLERGY PACKET PLEASE READ IMMEDIATELY AND BRING COMPLETED PACKET TO YOUR APPOINTMENT.

Objectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk?

Information for Vermont Prescribers of Prescription Drugs Long Form Bystolic (nebivolol) Tablets

Allergy Testing Information

ENT SURGICAL CONSULTANTS. LTD Glenwood Avenue, Joliet, Illinois * (815) Office (815) Allergy Dept. (815) Fax

Beta-Blocker Step Therapy Program

Prevention of Venous Thromboembolism

DENOMINATOR: All surgical patients aged 18 years and older undergoing procedures for which VTE prophylaxis is indicated in all patients

Data Dictionary ; Revised ; ; , Items in bold italics are recent changes/additions

Anticoagulation for prevention of venous thromboembolism

Texas Prior Authorization Program Clinical Criteria. Allergen Extracts

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 66 of 593

Quality Improvement Updates Foley Discontinuation Protocol Surgical Care Improvement Project

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Venous Thromboembolism. Prevention

Slide 1. Slide 2. Slide 3. Outline of This Presentation

sympathetic nerve impulses endogenous catecholamines beta adrenergic drugs

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

Misunderstandings of Venous thromboembolism prophylaxis

Clinical Policy: Ranolazine (Ranexa) Reference Number: CP.PMN.34 Effective Date: Last Review Date: 02.19

Measure #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients)

SURGICAL CARE IMPROVEMENT PROJECT QUALITY MEASURES

Stroke Quality Measures. Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed: May, 2012 Most recently updated: December 2012

THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY

Venous Thromboembolism Prophylaxis

Getting Started Kit VENOUS THROMBOEMBOLISM PREVENTION. Section 2: Evidence-Based Appropriate VTE Prophylaxis

Perioperative VTE Prophylaxis

Cardiac Medications At A Glance

2012 Core Measures. Acute Myocardial Infarction (AMI)

Comparison of Oral Beta-Blockers

INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY

Preventing and Managing High Blood Pressure

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN

To be ordered if results are not on the chart or have not already been ordered.

Venous Thromboembolism Prophylaxis - Why Should We Care? Harry Gibbs FRACP FCSANZ Vascular Physician The Alfred Hospital

UCLA Health System Apr - Jun 2013 (Q2)

South Carolina Department of Health and Human Services Post Office Box 8206 Columbia, South Carolina

The following report contains a description of the request, request specifications, and results from the modular program run(s).

Venous Thromboembolism Prophylaxis: Checked!

Study Exposures, Outcomes:

12.5mg, 25mg, 50mg. 25mg, 50mg. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg. -- $2.81 Acetazolamide (IR, 125mg, 250mg, 500mg (ER)

HEDIS. Quick Reference Guide. For more information, visit

Surgical Care, Pneumonia, Immunizations and Emergency Department Core Measures

HEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2016 Technical Specifications

This Core Measure Report shows performance to date. CAVEAT: Data collection is still in progress for the current and immediate past quarter!

SUNY Downstate Medical Center/University Hospital Oct - Dec 2013 (Q4)

SCORES FOR 4 TH QUARTER, RD QUARTER, 2014

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center

UW MEDICINE PATIENT EDUCATION. Get Active Your weight-loss success depends on it! Why is exercise so important? Your body needs exercise both

Tarkten A Pharr, MD, FACS 04/26/2018. VTE Prevention Strategies: Is a One Size Fits all Approach Correct?

Living with Congestive Heart Failure: A Guide to a Healthy Heart

Request for Administration of Immunotherapy At an Outside Medical Facility

Venous Thromboembolism National Hospital Inpatient Quality Measures

HEDIS. Quick Reference Guide. For more information, visit

Physician's Core Measure Pocket Guide AMI

VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies

CMS National Patient Safety Initiative for Surgical Care

Texas Sinus Center San Antonio La Cantera Pkwy, #20210 San Antonio, TX (210)

PERSISTENCE OF BETA BLOCKER TREATMENT AFTER A HEART ATTACK

REVISED RESPIRATORY MEDICATION USE QUESTIONNAIRE

e-module Centers for Medicaid and Medicare (CMS) Core Measures

100 mg atenolol equivalent to metoprolol

Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales

Texas Prior Authorization Program Clinical Edit Criteria

What evidence exists that describes the efficacy of mechanical prophylaxis for venous thromboembolism (VTE) in adult surgical patients?

GENERAL SURGICAL ADULT POST-OPERATIVE ORDERS 1 of 4

Quality Committee Core Measures Report AMI. Acute Myocardial Infarction

ADULT TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) TELEMETRY BED TRANSFER ORDERS 1 of 4

Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

Guideline Quick View: Venous Thromboembolism

The Royal College of Emergency Medicine. VTE Risk in Lower Limb Immobilisation in Plaster Cast 2015/2016

Disclosures. Venous Thromboembolism Prophylaxis: What every orthopaedic surgeon needs to know. Published Guidelines

Orthopedic Admission Hip Fracture Version 2 1/25/2017

Corporate Medical Policy

PET Cardiac Sarcoid Testing with Rest/Stress Test

National Quality Improvement Project 2018/2019 VTE Risk in Lower Limb Immobilisation Information Pack

These are guidelines only and can be deviated from if it is thought to be in the patient s best interest.

Patterns of Failure of a Standardized Perioperative Venous Thromboembolism Prophylaxis Protocol

Data Dictionary ; Revised ; ; , 07.07,09.07,04.08 Items in bold italics are recent changes/additions

Clinical Practice Guideline for Patients Requiring Total Hip Replacement

CARD THORACOTOMY PRE-OP PLAN

Medical History. Patient s Last Name: First: Middle Initial: DOB

Our Commitment to Quality and Patient Safety Core Measures

Venothromboembolism prophylaxis: Trauma and Orthopaedics Clinical guideline, V2

The NOF & NBHA Quality Improvement Registry

Integrating Sentinel into Routine Regulatory Drug Review: A Snapshot of the First Year. Risk of seizures associated with Ranolazine (Ranexa)

Measurement and Improvement of Quality of Cardiovascular Care DR : DEHESTANI

Codes for a Medicare claims-based model to predict LVEF class- User Guide

ASH Draft Recommendations for VTE Prevention in Surgical Hospitalized Patients DRAFT

Global Immunization Measures. Developed by: Kathy Wonderly RN, MSEd, CPHQ Consultant Created: September, 2011 Most recent update: December, 2018

*Corresponding Author:

LIMB COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS

What You Should Know

ALLERGY QUESTIONNAIRE. Patient Name

Venous thromboembolism: reducing the risk

ADULT CARDIAC SURGERY TELEMETRY BED TRANSFER ORDERS 1 of 4

Page: 1 of 13. Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

VENOUS THROMBOEMBOLISM (VTE) PREVENTION MEDICAL PROVIDER EDUCATION JUNE 2017

Transcription:

Developed by Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed : October 2009 Most recently updated: September 2011

To identify the patients who should receive a beta blocker during the perioperative period. To recognize the approved venous thromboembolism (VTE) prophylaxis for surgical patients. To recognize the importance of the VTE prophylaxis being started with 24 hours before to 24 hours after surgery Changes for 2012 will be in italics.

This is the only cardiac measure in the current SCIP program. Research has shown that mortality increases when patients who are on beta-blocker therapy prior to admission do not receive a betablocker during the perioperative period

For this measure the perioperative period is defined as the day prior to surgery through postoperative day two with day of surgery being day zero. If the patient s length of stay is less that 2 days the administration of the beta blocker the day prior to or day of surgery only are assessed.

Nursing role While ordering a medication is a physician responsibility, nurses should remind the physician that the patient was taking a beta blocker prior to admission. Nursing or often anesthesia will administer the medication as ordered. Be sure to document the date and time of the administration.

As with the other indicators if the practitioner does not order a beta blocker for patients who are on one prior to admission he/she must document the reason for not ordering this medication. Acceptable reasons include having a ventricular assist device or heart transplantation. The list of approved beta-blockers follows.

Approved Beta-Blockers Acebutolol Atenolol Atenolol/chlorthalidone Betapace Betapace AF Betaxolol Bisoprolol Bisoprolol/fumarate Bisoprolol/hydrochlorothiazide Blocadren Brevibloc Bystolic Carteolol Cartrol Carvedilol Coreg Corgard Corzide 40/5 Corzide 80/5 c Acebutolol Coreg

Approved Beta-blockers cont. Esmolol Inderal Inderal LA Inderide Inderide LA InnoPran XL Kerledex Kerlone Labetalol Levatol Lopressor Lopressor HCT Metoprolol Metoprolol/hydrochlorothiazide Metoprolol Tartrate/hydrochlorothiazide Nadolol Nadolol/bendroflumethiazide Nebivolol Nebivolol HCL Nebivolol Hydrochloride Normadyne

Approved Beta Blockers Normodyne Penbutolol Pindolol Propranolol Propranolol HCL Propranolol Hydrochloride Propranolol/hydrochlorothiazide Sectral Sorine Sotalol Sotalol HCL Tenoretic Tenormin Tenormin I.V. Timolide Timolol Timolol Maleate/hydrochlorothiazide Timolol/hydrochlorothiazide Reference: Specifications Manual for National Hospital Inpatient Quality Measures Discharges 01/01/12 (Q112) through 06/30/12(Q212)

The two VTE measures are interlinked. The first is that the appropriate VTE prophylaxis is ordered anytime from hospital arrival to 24 hours after the anesthesia end time. This is a practitioner driven measure. The second is that the ordered VTE prophylaxis is initiated within 24 hours prior to the anesthesia start time to 24 hours after the anesthesia end time. This is a nursing driven measure.

There are several groups of patients who are excluded from this indicator. These include: Burn patients Patients whose total surgical time is less than 60 minutes Patients who stay less than two nights. Patients who are on oral anticoagulation therapy prior to admission.

There are two types of prophylaxis. 1. Pharmacological which include: Heparin Low molecular weight heparin such as Lovonox Factor Xa inhibitor fondaparinux Arixtra or Xarelto Warfarin (Coumadin)

2. Mechanical prophylaxis which include : Graduated Compression Stockings (GCS) Intermittent Pneumatic Compression Devices (IPC) Venous Foot Pump (VFP)

Years of research have identified that the type of procedure done drives the choice of VTE prophylaxis. The following slides show the recommendations for each category of surgery. While ordering prophylaxis is the responsibility of the practitioner, the nurses caring for post-op patients should look for some type of order or documentation as to why nothing was ordered.

Procedure Recommended prophylaxis Elective Total Knee Replacement Hip Fracture surgery Elective Total hip replacement Any of the following Low molecular weight heparin Factor Xa inhibitor including oral route (Xarelto) Warfarin ICP VFP Low molecular weight inhibitor Low dose unfractionated heparin Factor Xa Inhibitor Warfarin Low molecular weight heparin Factor Xa inhibitor including oral route (Xarelto) Warfarin

Elective Total hip replacement with reason documented for not administering pharmacological VTE Intermittent Pneumatic Compression device (ICP) Venous Foot Pump VFP Hip Fracture surgery with reason documented for not administering pharmacological VTE Urologic Surgery Graduated Compression Stockings (GCS) Intermittent Pneumatic Compression device (ICP) Venous Foot Pump VFP Low molecular weight inhibitor Low dose unfractionated heparin Factor Xa Inhibitor IPC GCS Pharmacological combined with IPC or GCS

General Surgery General surgery with reason documented for not receiving pharmacological VTE Gynecologic Surgery Intracranial Neurosurgery Low molecular weight inhibitor Low dose unfractionated heparin Factor Xa Inhibitor Pharmacological combined with IPC or GCS GCS IPC Low molecular weight inhibitor Low dose unfractionated heparin Factor Xa Inhibitor IPC Pharmacological combined with IPC or GCS Low molecular weight inhibitor Low dose unfractionated heparin IPC with or without GCS Any combination of the pharmacological and mechanical listed above.

As you see in the previous charts the first choice of prophylaxis for VTE prevention is medication with or without any mechanical device use. When the patient has a documented contraindication such as recent GI bleed, the mechanical device prophylaxis can be used alone.

Regardless of the treatment ordered it must be initiated in the time frame of 24 hours prior to anesthesia start time to 24 hours after the anesthesia end time. Nursing and Pharmacy need to work together to assure the medications are available, administered and the start time documented within this window.

The SCIP core measure set is the most complicated of all. Not only are there the most measures but there are specific time limits designated for six of these indicators. The role of nursing is huge. Not only do you need to know the recommendations but you must be sure that each measure is addressed within the designated timeframe. As with the other CMS core measures each indicator requires an action and concise documentation.

Reducing the complications of surgery continues to be one of the National Patient Safety Goals and a goal of the health care reform movement. While there are no new measures added through 06/30/2012 there are surgical measures included in the list under consideration for future use.

1. Patients who are taking a beta blocker prior to arrival for surgery and receive general anesthesia should have a dose given during the perioperative period which ends at discharge from PACU. A. True B. False

2. The SCIP VTE measures will be met as long as you get that patient out of bed on post-op day 1. A. True B. False

3. Heparin or Lovonox can be given up to hour(s) before anesthesia start time and still be considered appropriate treatment according to the SCIP guidelines. A. 4 B. 16 C. 24 D. 48

4. The first choice for VTE prophylaxis is pharmacological with or without a mechanical device. A. True B. False